Clinical comparison of the positron emission tracking (PeTrack) algorithm with the real‐time position management system for respiratory gating in cardiac positron emission tomography

2020 ◽  
Vol 47 (4) ◽  
pp. 1713-1726 ◽  
Author(s):  
Spencer Manwell ◽  
Ran Klein ◽  
Tong Xu ◽  
Robert A. deKemp
2006 ◽  
Vol 33 (6Part7) ◽  
pp. 2066-2066
Author(s):  
A Hsu ◽  
B Thorndyke ◽  
T Pawlicki ◽  
L Xing

2008 ◽  
Vol 55 (5) ◽  
pp. 2531-2540 ◽  
Author(s):  
P. Guerra ◽  
J.E. Ortuno ◽  
G. Kontaxakis ◽  
M.J. Ledesma-Carbayo ◽  
J.J. Vaquero ◽  
...  

Author(s):  
Nikant Sabharwal ◽  
Parthiban Arumugam ◽  
Andrew Kelion

As in single photon emission computed tomography (SPECT), positron emission tomography (PET) involves the injection of a radiopharmaceutical, the physiological properties of which determine its distribution within the patient. The labelling radionuclide then allows this distribution to be imaged. The value of cardiac PET as a routine clinical tool, particularly for perfusion imaging, was previously limited by the expense and scarcity of cameras and the short half-lives of the radionuclides with complex radiochemistry. The need for an on-site cyclotron to produce these radiopharmaceuticals made a clinical service non-viable. A number of recent developments, however, have led to renewed interest in cardiac PET. This chapter covers PET instrumentation, detail on the radiopharmaceuticals used in cardiac PET, and a number of sections on F-fluorodeoxyglucose (F-FDG) PET covering infection and inflammation imaging.


Sign in / Sign up

Export Citation Format

Share Document